Jones Hill Capital LP
CIK 2102314 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $470.4M
- Posisi
- 29
- Per tanggal
- 30 Juni 2026
#3.930 dari 9.443 berdasarkan nilai 13F · top 41.6%
Nilai portofolio QoQ: +0.8% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 68,84%
- Bobot 25 kepemilikan teratas
- 98,59%
- Posisi di atas 1%
- 25
- Jumlah posisi efektif
- 14,7
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 58,88% Perkiraan pembelian $275.809.337 · penjualan $311.555.215
- Posisi baru
- 15
- Meningkat
- 5
- Menurun
- 9
- Tertutup
- 12
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 94,1% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
98,2%
Lainnya/Tidak terpetakan
1,8%
Portofolio lengkap 29 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $81.915.580 | 17,42% | 1.431.590 | $10.264.229 | Naik ×1 | ||
| GILD Gilead Sciences, Inc. - Common Stock | $43.340.053 | 9,21% | 343.043 | Naik ×1 | |||
| ARQT Arcutis Biotherapeutics, Inc. - Common stock | $28.571.960 | 6,07% | 1.089.701 | Naik ×1 | |||
| MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | $28.214.038 | 6,00% | 52.545 | Naik ×1 | |||
| BCAX Bicara Therapeutics Inc. - Common Stock | $26.501.917 | 5,63% | 892.621 | $1.437.812 | Turun ×1 | ||
| RLMD Relmada Therapeutics, Inc. - Common Stock | $25.293.119 | 5,38% | 3.655.075 | $22.907.565 | Naik ×1 | ||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $24.976.304 | 5,31% | 1.339.212 | $20.560.116 | Naik ×1 | ||
| PHVS Pharvaris N.V. - Ordinary Shares | $23.441.056 | 4,98% | 677.879 | $18.722.910 | Naik ×1 | ||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $22.206.444 | 4,72% | 367.900 | Naik ×1 | |||
| ANIP ANI Pharmaceuticals, Inc. - Common Stock | $19.354.626 | 4,11% | 233.808 | $-5.145.022 | Turun ×1 | ||
| IMCR Immunocore Holdings plc - American Depositary Shares | $16.283.178 | 3,46% | 512.856 | Naik ×1 | |||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $16.057.282 | 3,41% | 894.058 | $-6.165.955 | Turun ×1 | ||
| INSM Insmed Incorporated - Common Stock | $13.047.622 | 2,77% | 122.375 | Naik ×1 | |||
| NUVL Nuvalent, Inc. - Class A Common Stock | $12.157.587 | 2,58% | 98.442 | $-18.662.447 | Turun ×1 | ||
| CAPR Capricor Therapeutics, Inc. - Common Stock | $10.131.684 | 2,15% | 420.751 | $-17.508.209 | Turun ×1 | ||
| ACRS Aclaris Therapeutics, Inc. - Common Stock | $9.307.713 | 1,98% | 1.759.492 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 4525EP200) | $8.296.941 | 1,76% | 539.814 | Naik ×1 | |||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $8.093.400 | 1,72% | 747.313 | Naik ×1 | |||
| TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | $7.980.461 | 1,70% | 625.428 | $1.763.866 | Naik ×1 | ||
| SNDX Syndax Pharmaceuticals, Inc. - Common Stock | $7.432.400 | 1,58% | 340.000 | Naik ×1 | |||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $7.182.817 | 1,53% | 574.166 | Naik ×1 | |||
| VIR Vir Biotechnology, Inc. - Common Stock | $6.717.380 | 1,43% | 659.213 | $-4.018.608 | Turun ×1 | ||
| CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | $6.130.505 | 1,30% | 653.572 | Naik ×1 | |||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $5.566.108 | 1,18% | 57.100 | Naik ×1 | |||
| VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $5.525.128 | 1,17% | 11.123 | $-42.970.456 | Turun ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $2.529.888 | 0,54% | 49.850 | $-20.717.280 | Turun ×1 | ||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $2.177.231 | 0,46% | 40.567 | $-2.671.352 | Turun ×1 | ||
| PHAT Phathom Pharmaceuticals, Inc. - Common Stock | $1.752.123 | 0,37% | 161.486 | Naik ×1 | |||
| ACHV Achieve Life Sciences, Inc. - Common Shares | $174.743 | 0,04% | 26.760 | Naik ×1 | |||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| GILD | $43.340.053 | 343.043 | 9,21% |
| ARQT | $28.571.960 | 1.089.701 | 6,07% |
| MDGL | $28.214.038 | 52.545 | 6,00% |
| XENE | $22.206.444 | 367.900 | 4,72% |
| IMCR | $16.283.178 | 512.856 | 3,46% |
| INSM | $13.047.622 | 122.375 | 2,77% |
| ACRS | $9.307.713 | 1.759.492 | 1,98% |
| Penerbit tidak dikenal (CUSIP: 4525EP200) | $8.296.941 | 539.814 | 1,76% |
| ORIC | $8.093.400 | 747.313 | 1,72% |
| SNDX | $7.432.400 | 340.000 | 1,58% |
| OLMA | $7.182.817 | 574.166 | 1,53% |
| CRBP | $6.130.505 | 653.572 | 1,30% |
| DNTH | $5.566.108 | 57.100 | 1,18% |
| PHAT | $1.752.123 | 161.486 | 0,37% |
| ACHV | $174.743 | 26.760 | 0,04% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| PHVS | Beli lebih banyak | +511K | +$18.7M |
| NUVL | Dipangkas | -202K | -$18.7M |
| CAPR | Dipangkas | -488K | -$17.5M |
| BMRN | Beli lebih banyak | +163K | +$10.3M |
| AMLX | Dipangkas | -705K | -$6.2M |
| ANIP | Dipangkas | -85K | -$5.1M |
| VIR | Dipangkas | -539K | -$4.0M |
| GPCR | Dipangkas | -60K | -$2.7M |
| TNXP | Beli lebih banyak | +173K | +$1.8M |
| BCAX | Dipangkas | -368K | +$1.4M |
4 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| PCVX | 30 Juni 2026 | 644.831 | $37.471.129 | 7,2% |
| TERN | 30 Juni 2026 | 521.237 | $27.479.615 | Tidak lagi dilacak |
| RARE | 30 Juni 2026 | 1.165.557 | $24.418.419 | -21,8% |
| ARGX | 30 Juni 2026 | 25.995 | $18.982.849 | 11,7% |
| FULC | 30 Juni 2026 | 1.771.926 | $13.590.672 | 6,0% |
| NUVB | 30 Juni 2026 | 2.383.031 | $10.223.203 | 23,0% |
| ORKA | 30 Juni 2026 | 140.843 | $6.908.349 | 12,4% |
| CTNM | 30 Juni 2026 | 513.053 | $6.700.472 | -2,4% |
| MANE | 30 Juni 2026 | 100.843 | $6.368.235 | -14,8% |
| TRDA | 30 Juni 2026 | 374.010 | $4.720.006 | 4,2% |
| SLN | 30 Juni 2026 | 301.604 | $1.589.453 | 20,8% |
| AVBP | 30 Juni 2026 | 45.809 | $1.056.814 | -15,5% |